Exercise training for cardiovascular prevention in patients with cancer A scientific statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology
European Heart Journal
Abstract
Patients with cancer usually report limitations of their functional capacity, which may range from subclinical impairment of cardiopulmonary exercise reserve to poor quality of life with physical, cognitive, or psychosocial consequences. Exercise training is a potent multi-targeted approach to control pre-existing and new risk factors. Preliminary evidence shows that it is associated with a lower risk of cancer therapy-related cardiotoxicity and increased self-reported well-being in patients with cancer. Current evidence demonstrates that supervised exercise therapy, including high-intensity interval training, is safe and well-tolerated and reduces risk in subjects with cancer in the pre-, active-, and post-treatment settings. The present consensus document will discuss the role of exercise training in cardio-oncology, focusing on patients with cardiovascular diseases induced by cancer treatment and on those who received cardiotoxic therapies.
Contributors
Alain Cohen-Solal
Author
Pietro Ameri
Author
Matthias Totzeck
Author
Beatrice Fervers
Author
Gilles de Keulenaer
Author
Marie McLaughlin
Author
Matthias Wilhelm
Author
Flavio D’Ascenzi
Author
Piergiuseppe Agostoni
Author
Martin Halle
Author
Jessica M Scott
Author
Lee W Jones
Author
Stephan Von Haehling
Author
Stamatis Adamopoulos
Author
Elena Marques Sule
Author
Najat Mouine
Author
Francesco Orso
Author
Geza Halasz
Author
Stefania Paolillo
Author
Giuseppe Vergaro
Author
Amam Chinyere Mbakwem
Author
Thomas Suter
Author
Alexander Lyon
Author
Brenda Moura
Author
Petar Seferovic
Author
Giuseppe Rosano
Author
You may be interested in
